<?xml version="1.0" encoding="UTF-8"?>

<rss version="2.0">
  <channel>
    <title>HIV/AIDS Treatment News from POZ and AIDSmeds</title>
    <link>http://www.poz.com</link>
    <description><![CDATA[POZ, founded in 1994, and AIDSmeds, founded in 1999, are dedicated to providing people living with HIV/AIDS with the information they need to make empowered treatment decisions. ]]></description>
    <TTL>3</TTL>
    <generator>Smart &amp; Strong CMS 3.1.0</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <language>en</language>
    <pubDate>Wed, 8 Feb 2012 15:04:15 -0500</pubDate>
    <lastBuildDate>Wed, 8 Feb 2012 15:04:15 -0500</lastBuildDate>
    <item>
      <title>Merck Warns of Victrelis and HIV Protease Inhibitor Interactions</title>
      <link>http://www.poz.com/rssredir/articles/hiv_hcv_victrelis_761_21880.shtml</link>
      <description><![CDATA[
The hepatitis C protease inhibitor Victrelis (boceprevir) has some significant drug-drug interactions with common Norvir (ritonavir)?boosted protease inhibitor (PI) combinations, according to preliminary data from a clinical trial and a warning issued to health care providers by Merck on February 6.&nbsp;




]]></description>
      <pubDate>Wed, 8 Feb 2012 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Spinal Cord Stimulation Shows Potential for Peripheral Neuropathy</title>
      <link>http://www.poz.com/rssredir/articles/hiv_spinal_neuropathy_761_21869.shtml</link>
      <description><![CDATA[Electrical stimulation of the spinal cord markedly reduced peripheral neuropathy (PN)associated pain in a man living with HIV who didn&#8217;t respond to more conventional PN therapies, according to a February 5 presentation at the 6th World Congress of the World Institute of Pain in Miami and reported by Medscape.&nbsp;


]]></description>
      <pubDate>Tue, 7 Feb 2012 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>CDC Recommends HPV Vaccine for Boys and Young Men, Hep B Vaccine for Diabetics</title>
      <link>http://www.poz.com/rssredir/articles/hpv_hbv_vaccine_761_21864.shtml</link>
      <description><![CDATA[It&#8217;s official: All males between 11 and 21 years of age should be vaccinated against human papillomavirus (HPV), a leading cause of oral, genital and anal cancers, according to new U.S. Centers for Disease Control and Prevention guidelines published February 3 in the health agency&#8217;s Morbidity and Mortality Weekly Report. HPV vaccination is also recommended for previously unvaccinated men between 22 and 26 years of age who have compromised immune systems, are HIV positive or have sex with other men.&nbsp;


]]></description>
      <pubDate>Mon, 6 Feb 2012 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Isentress, Intelence, Prezista Regimen Goes the Distance for HIV Treatment Veterans</title>
      <link>http://www.poz.com/rssredir/articles/isentress_prezista_experienced_761_21851.shtml</link>
      <description><![CDATA[A drug regimen containing Isentress (raltegravir), Intelence (etravirine) and Norvir (ritonavir)boosted Prezista (darunavir) has been shown to be &#8220;highly potent and durable in terms of efficacy and safety&#8221; in a French clinical trial involving heavily treatment-experienced people living with HIV. According to the research paper published ahead of print by the Journal of Acquired Immune Deficiency Syndromes (JAIDS), 88 percent of those using this regimen had undetectable viral loads after nearly two years of treatment.


]]></description>
      <pubDate>Thu, 2 Feb 2012 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Awareness, Testing Needed to Curb Hep C Infections Among HIV-Positive Gay Men</title>
      <link>http://www.poz.com/rssredir/articles/hiv_hepatitis_coinfection_1667_21837.shtml</link>
      <description><![CDATA[
A new report by the National AIDS Trust (NAT), a leading HIV organization in the United Kingdom, concludes that much more needs to be done to address the burgeoning epidemic of hepatitis C virus (HCV) infection among gay men living with HIV.




]]></description>
      <pubDate>Tue, 31 Jan 2012 00:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Alcohol Treatment Boosts Hep C Cure Rates Among Drinkers</title>
      <link>http://www.poz.com/rssredir/articles/hepatitis_alcohol_treatment_1667_21832.shtml</link>
      <description><![CDATA[People who drink&#8212;even heavily&#8212;can successfully undergo treatment for hepatitis C virus (HCV) if they&#8217;re provided with individualized, multidisciplinary care that also addresses their alcohol use, according to a study published in the February 2012 issue of Journal of Hepatology.&nbsp;


]]></description>
      <pubDate>Mon, 30 Jan 2012 00:00:00 -0500</pubDate>
    </item>
  </channel>
</rss>

